J&J Medical Connect
BALVERSA®

(erdafitinib)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can I Take BALVERSA if I am Pregnant, Breastfeeding, or if I Have a Partner That Can Become Pregnant?

Last Updated: 09/12/2024

summary

The following content from the BALVERSA PATIENT INFORMATION may be helpful to address your question:  

Can I take BALVERSA if I am pregnant, breastfeeding, or if I have a partner that can become pregnant?

Before taking BALVERSA tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. BALVERSA can harm your unborn child. You should not become pregnant during treatment with BALVERSA.1
    • Females who can become pregnant:
      • Your healthcare provider may do a pregnancy test before you start treatment with BALVERSA.
      • You should use effective birth control during treatment and for 1 month after the last dose of BALVERSA. Talk to your healthcare provider about birth control methods that may be right for you.
      • Tell your healthcare provider right away if you become pregnant or think you may be pregnant.
    • Males with female partners who can become pregnant:
      • You should use effective birth control when sexually active during treatment with BALVERSA and for 1 month after the last dose.
  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 1 month after the last dose of BALVERSA.1

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for BALVERSA.1

 

References

1 BALVERSA (erdafitinib) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/BALVERSA-pi.pdf.